Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Effects of Weight Loss Surgery on Bone Health in Adolescents

Active, not recruiting

Conditions: Obesity
Surgery

Interventions: Procedure: Roux-en-Y Gastric Bypass
Procedure: Vertical Sleeve Gastrectomy

First Posted Date: 2015-09-23

Last Posted Date: 2024-03-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 240

Registration Number: NCT02557438

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Fostering Resilience to Psychosocial and HIV Risk in Indian MSM

Not Applicable

Completed

Conditions: Health Behavior
Sexual Behavior
HIV Infection

Interventions: Behavioral: HIV/STI counseling and testing
Behavioral: Self-acceptance based intervention

First Posted Date: 2015-09-22

Last Posted Date: 2019-10-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 608

Registration Number: NCT02556294

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇮🇳
The Humsafar Trust, Mumbai, India
🇮🇳
The National Institute for Research in Tuberculosis, Chennai, India

VoIce Changes and Heart Failure

Conditions: Congestion
Pitch
Heart Failure
Voice

First Posted Date: 2015-09-22

Last Posted Date: 2015-09-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT02555904

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach

Phase 2

Completed

Conditions: Major Depressive Disorder
Overweight
Inflammation

Interventions: Drug: EPA 4 g/day
Other: Placebo
Drug: EPA 2 g/day
Drug: EPA 1 g/day

First Posted Date: 2015-09-18

Last Posted Date: 2022-05-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 61

Registration Number: NCT02553915

Locations: 🇺🇸
Depression Clinical and Research Program at Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States

Improving Comprehensive Cancer Screening Among Vulnerable Patients Using Patient Navigation

Not Applicable

Completed

Conditions: Patient Compliance

Interventions: Behavioral: Patient Navigation

First Posted Date: 2015-09-17

Last Posted Date: 2018-03-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1612

Registration Number: NCT02553538

Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients

Not Applicable

Completed

Conditions: Hypertension
Prehypertension
Diabetes Mellitus, Type 2
Prediabetic State
Obesity

Interventions: Other: FeatForward App (on study smartphone)

First Posted Date: 2015-09-16

Last Posted Date: 2020-09-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 300

Registration Number: NCT02551640

Locations: 🇺🇸
Mass General: Charlestown Healthcare Center, Charlestown, Massachusetts, United States
🇺🇸
Mass General Revere HealthCare Center, Revere, Massachusetts, United States

a4b7 Integrin in Eosinophilic Esophagitis

Completed

Conditions: Eosinophilic Esophagitis

Interventions: Other: Eosinophil isolation and characterization.

First Posted Date: 2015-09-10

Last Posted Date: 2019-02-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT02546219

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Ketamine for Depression: An MRI Study

Phase 4

Completed

Conditions: Anxious Depression
Depression
Major Depressive Disorder

Interventions: Drug: Ketamine
Other: Magnetic Resonance Imaging (MRI)

First Posted Date: 2015-09-09

Last Posted Date: 2019-04-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT02544607

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Completed

Conditions: HIV

Interventions: Other: Arterial Imaging

First Posted Date: 2015-09-07

Last Posted Date: 2022-04-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT02542371

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

PK/PD Pediatric ADHD Classroom Study

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Drug: Methylphenidate HCl ER tablets 2
Drug: Methylphenidate HCl ER tablets 1
Drug: Placebo
Drug: Methylphenidate HCl ER for suspension

First Posted Date: 2015-08-31

Last Posted Date: 2019-12-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 88

Registration Number: NCT02536105

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy